spirogermanium has been researched along with Nervous System Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajani, JA; Bodey, GP; Legha, SS | 1 |
| Connors, JM; Eisenhauer, E; Maroun, J; Quirt, I; Skillings, J | 1 |
2 other study(ies) available for spirogermanium and Nervous System Disorders
| Article | Year |
|---|---|
Phase I study of spirogermanium given daily.
Topics: Adult; Aged; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Germanium; Humans; Infusions, Parenteral; Lymphoma; Male; Middle Aged; Nausea; Nervous System Diseases; Organometallic Compounds; Ovarian Neoplasms; Spiro Compounds | 1983 |
A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study.
Topics: Aged; Antineoplastic Agents; Drug Evaluation; Germanium; Humans; Lymphoma; Middle Aged; Nervous System Diseases; Organometallic Compounds; Prognosis; Spiro Compounds | 1985 |